Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Plos One|November 2, 2012
The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animalsAnne Klomp, Bjørnar den Hollander, Kora de Bruin, et al.The International Journal of Neuropsychopharmacology|December 19, 2014
Manganese-enhanced magnetic resonance imaging reveals differential long-term neuroadaptation after methamphetamine and the substituted cathinone 4-methylmethcathinone (mephedrone)Bjørnar den Hollander, Mateusz Dudek, Ilkka Ojanperä, et al.Duodecim; Laaketieteellinen Aikakauskirja|November 12, 2011
[Designer drugs in Finland]Ulrich Tacke, Bjørnar den Hollander, Kaarlo Simojoki, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 30, 2011
Preliminary evidence of hippocampal damage in chronic users of ecstasyBjørnar den Hollander, Marieke Schouw, Paul Groot, et al.Pharmacology, Biochemistry, and Behavior|October 27, 2012
Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedroneBjørnar den Hollander, Stanislav Rozov, Anni-Maija Linden, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|June 11, 2014
Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedroneBjørnar den Hollander, Mira Sundström, Anna Pelander, et al.Scientific Reports|October 15, 2015
Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cellsBjørnar den Hollander, Mira Sundström, Anna Pelander, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 2013
Neurosteroid Agonist at GABAA receptor induces persistent neuroplasticity in VTA dopamine neuronsElena Vashchinkina, Aino K Manner, Olga Vekovischeva, et al.Pharmacological Reviews|September 26, 2015
Mechanisms of Action and Persistent Neuroplasticity by Drugs of AbuseEsa R Korpi, Bjørnar den Hollander, Usman Farooq, et al.Cancer Investigation|November 9, 2016
Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian CancerBrian Y Park, Rachel N Grisham, Bjørnar den Hollander, et al.Pageof 2